Login / Signup

Effect of the 5-HT4 receptor agonist tegaserod on the expression of GRK2 and GRK6 in the rat gastrointestinal tract.

Teshome NediPaul J WhiteIan M CouparHelen R Irving
Published in: BMC research notes (2018)
Rats were treated with a single dose of tegaserod (5 mg/kg) and tissue samples of the oesophagus and distal colon were prepared and level of GRK2 and GRK6 protein expression was determined using western blotting. The immunodensity of GRK2 and GRK6 was normalized against the loading control β-actin and compared with control animals. Acute administration of tegaserod for 1, 2, 3, 4, 6, and 8 h did not change significantly the immunodensity of GRK2 or GRK6 in the oesophagus or GRK2 in the distal colon when compared with control animals. This may indicate that the basal level of GRK2 and GRK6 expression is sufficient to regulate the desensitization of 5-HT4 receptors in acute drug treatment.
Keyphrases
  • poor prognosis
  • liver failure
  • emergency department
  • oxidative stress
  • intensive care unit
  • south africa
  • respiratory failure
  • hepatitis b virus
  • aortic dissection
  • smoking cessation